OKX Tokenized Stocks: Why 26 Companies Objected
Intel, IBM, Oracle and IonQ joined 22 companies objecting to OKX-ICE tokenized stock listings. Learn what the 26 objections mean for issuers and markets.

Why 26 Companies Don't Want Their Stocks on OKX-ICE
Intel, IBM, Oracle and IonQ have joined a growing list of companies objecting to plans by crypto exchange OKX and Intercontinental Exchange (ICE) to list their US stocks in tokenized form. With the latest additions, the reported total is 26 out of 62 companies initially proposed. In other words, objections make up about 42% of that first group.
That number matters - but it's easy to overread it. An objection to one exchange's proposal isn't automatically a rejection of tokenization across the board. And even if there's a regulatory route for limited tokenized-stock trading, it doesn't mean every issuer plans to participate. For companies, the real questions are practical: control over how shares are represented, what investors actually receive, which venues handle trading, and what operational and legal risks come with all of it.
This article breaks down what the OKX-ICE proposal is, what tokenized stocks can mean in practice, why some issuers may choose to opt out, and how to interpret the expanding list without treating it as a readout on the entire market.
What happened with the OKX-ICE tokenized stock plan?
In a Monday update to its proposed OKXICE exchange, OKX said Intel, IBM, Oracle and IonQ had added their names to a list of companies objecting to having their US stocks offered in tokenized form. The total reached 26. Alphabet, Wells Fargo and Goldman Sachs were among the other companies previously reported as objecting.
OKX and ICE had proposed 62 companies for tokenized listings in a filing under a temporary US regulatory exemption. Based on the reported figures, 26 of the 62 proposed issuers had objected - about 42%. That's a sizable share of this proposal, but it doesn't mean 42% of US public companies reject tokenized securities. The denominator here is the specific set of companies named in this plan - not the broader stock market.
What the proposal is - and what it is not
The plan followed US Securities and Exchange Commission (SEC) approval of temporary innovation exemptions for tokenized US stocks. The source report says these exemptions allow Tokenized Securities Venues (TSVs) to offer limited trading in tokenized National Market System (NMS) stocks. In other words, it's a bounded regulatory pathway, not a blanket endorsement of every tokenized-stock product - or a general signal that issuers are supposed to participate.
That distinction is important. A regulatory exemption can give a venue permission to test a defined activity. It doesn't resolve the details of issuer consent, investor protections, how a token maps to a security, or how trading fits into existing market infrastructure. Those points depend on the specific product and rules being used.
Why the number attracted attention
The proposed names included well-known public companies, many of which trade on Nasdaq or the New York Stock Exchange. When a plan lists a lot of big issuers, it can start to look like adoption is already happening. The objections are a reminder that the comparison doesn't hold: being named in an initial proposal isn't the same as an issuer agreeing to participate.
Former New York Governor Andrew Cuomo, a co-chair of the tokenization venture, described the objections as a "very natural response" and said he expected more names to be added. That suggests the process is still unfolding, not a settled roster. For now, the reported numbers reflect objections to one proposal - not whether tokenized securities are broadly succeeding or failing.
What does a tokenized stock actually represent?
A tokenized stock is a digital token meant to give exposure to, or represent, a share or another security. The label by itself doesn't tell you what legal rights the holder receives. The token could represent a direct interest in a security, or it could offer economic exposure through a different setup. What matters is the legal structure and custody model, not the word "tokenized."
For buyers, those differences can affect voting rights, dividends, transfer limits, and what happens if an intermediary fails. It also affects whether the holder is treated as a recognized shareholder, whether a custodian holds the underlying shares, and what claims a token holder can make if something goes wrong with the issuer or the platform. These terms should be clear before trading begins.
The token is only one part of the system
A tokenized-securities product doesn't rely on a blockchain ledger alone. At minimum, the setup has to specify:
- The legal claim: What does a token holder own, or have the right to claim?
- The underlying asset: Is there a corresponding share, and who holds it?
- The record of ownership: Which system decides who the legally recognized owner is?
- Trading and settlement: How are trades matched, cleared and settled, and when does a transfer become final?
- Corporate actions: How are dividends, voting and other issuer events handled?
- Failure procedures: What happens if the venue, custodian or technology provider stops operating?
Blockchain can change how records and transfers are handled in some areas. It doesn't automatically solve the legal, custody or governance questions. If different systems keep different versions of ownership, the product needs a clear rule for which record counts and how disputes are handled.
Why public-company issuers have a direct interest
A company may not run the venue, but its name and shares are central to the proposed product. It has a real interest in how its security is represented, what information investors receive, and whether the arrangement fits the rules around its existing listing. A tokenized version that trades through another venue can also raise issues around fragmentation, customer support, and how corporate actions are processed.
So an issuer's objection shouldn't be reduced to "the company dislikes blockchain." The objection could be about the specific structure, terms, or oversight of this offering. Without the detailed basis for each company's stance, it's not possible to say the issuers share the same underlying concern. The takeaway is narrower: these companies don't want their securities included in this particular setup right now.
Why are companies objecting to the proposed listings?
The reported update tells you which companies objected, but it doesn't provide detailed reasons for each one. Any attempt to explain motives has to separate confirmed facts from reasonable business concerns. The underlying reasons likely vary by issuer.
A practical way to think about the decision is to look at the risk surface. Companies already handle investor relations, disclosure obligations, transfer processes, and relationships with regulated exchanges and intermediaries. A new venue - or a new way of representing shares - adds complexity. If the upside isn't clear yet and the operational and legal responsibilities are still forming, opting out can be the sensible choice.
Control, investor rights and clarity
An issuer may want clarity on whether a token holder gets the same rights as a traditional shareholder. If rights differ, the product needs to spell that out clearly. Without that, investors can end up confused, complaints can rise, reputational damage can follow, and disputes can break out over voting or corporate actions. Companies also have to ask whether the documentation and disclosures give investors a fair understanding of what they're actually buying.
Control is another practical concern. If an issuer hasn't approved a specific representation of its shares, it may object to its name being included in the product - or to the implication that it endorses the offering. That's separate from whether tokenization could work under different terms, on a different venue, or under a different regulatory structure.
Compliance and operational costs
A new trading path can add work across legal, compliance, finance and investor-relations teams. Staff may need to review custody arrangements, settlement workflows, disclosures, corporate-action handling, and processes for complaints or errors. Those costs are ongoing, not just a one-time launch burden.
The math shifts if a proposal offers genuinely clear benefits - like broader access or more efficient settlement - and includes the right controls. But "on-chain" by itself isn't usually enough. The core question is whether the product improves access or operations without making ownership, oversight or customer outcomes harder to manage.
Existing exchanges are part of the context
Nasdaq issued guidance in September advising companies considering the innovation exemption to be "cautious." Nasdaq has also invested $100 million in Payward, the parent company of Kraken, as part of its own work in tokenized assets. Taken together, these points suggest established market players are exploring the category while also signaling that participation requires care.
That doesn't contradict itself. An exchange can see potential in tokenization and still urge issuers to scrutinize the specific exemption and product. In real markets, adoption depends on how the offer is structured, who owns which responsibilities, and whether the economics justify the added workload. An issuer opting out now doesn't tell you what it might do later under a more clearly defined arrangement.
What do 26 objections mean for tokenized markets?
The first takeaway is that issuer participation can't be assumed. If a venue floats a list of companies before confirming they're actually willing to be included, it's more accurate to treat the list as a proposed universe than as an approved product roster. That distinction matters for how investors, partners and the press describe what's being offered.
The second takeaway is that regulatory permission and commercial acceptance are separate gates. A temporary exemption might let a venue test a limited service. Issuers still have to decide whether they want their securities represented and traded through it. Then venues, custodians and investors each bring their own requirements around compliance, risk management and product design.
A practical adoption framework
For any tokenized-stock proposal, it helps to check progress across four layers:
- Regulatory scope: What activities does the exemption allow, for how long, and under what conditions? A temporary pathway shouldn't be treated as permanent approval.
- Issuer participation: Did each company agree to this use of its security, or is it just named in an initial filing? Don't assume "named" equals "participating."
- Investor rights and safeguards: What does the token represent legally, who holds the underlying asset, and how are voting, dividends and disputes handled?
- Market operations: Can the system support custody, settlement, disclosures and failure handling in a way that investors and counterparties can rely on?
Progress can be real in one layer and still stalled in another. A venue might have permission to run a limited test without having secured broad issuer participation. Conversely, companies could be open to tokenization in principle but reject a proposal if the terms or underlying infrastructure don't match what they need.
What to watch next
It's not just about whether the objection count rises or falls. Watch for clearer information on which companies have actually agreed to participate, what rights the tokens confer, and how the venue plans to handle custody and corporate actions. The terms of the regulatory exemption - and any updates to the initial company list - also matter.
For investors, don't treat an announced tokenized listing as the same thing as owning a conventional share. Read the product documents, figure out who is responsible for the underlying asset, and understand how the token can be transferred or redeemed. If those details are missing or hard to verify, the headline announcement isn't enough to establish what you'd actually own.
For companies considering similar proposals, it's worth running the same kind of practical review: involve legal, compliance, finance and investor-relations teams; ask who carries each operational responsibility; and consider what happens to existing shareholders if things go wrong. The point isn't to dismiss the technology out of hand. It's to make sure the benefits are concrete and the obligations are clearly assigned before launch.
Conclusion: treat the list as a signal, not a verdict
The 26 reported objections make one thing clear: a proposed tokenized-stock listing isn't the same as issuer consent. OKX-ICE started with 62 proposed companies, and more than four in ten had objected by the time of the reported Monday update. That's a real hurdle for this particular plan - but it's not a verdict on tokenized securities as a whole.
The practical test is whether a product can align regulatory scope, issuer participation, investor rights and reliable market operations. Until those pieces are clearly defined, it's safer to treat announced company lists as proposals, not proof of adoption - and to look closely at what a token actually represents before drawing conclusions.